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Organogenesis of the endocrine pancreas. Embryonic pancre-
atic primordia transplanted into diabetic animal hosts undergo
selective endocrine differentiation in situ and normalize glu-
cose tolerance. Pancreatic primordia can be transplanted across
isogeneic, allogeneic, and both concordant (rat to mouse) and
highly disparate (pig to rodent) xenogeneic barriers. This review
explores the therapeutic potential for pancreatic organogenesis
posttransplantation of embryonic primordia.
Recently, as part of the proceedings for the Interna-
tional Society of Nephrology Forefronts symposium, Vas-
cular Repair and Regulation in Kidney Disease, held in
Dresden, Germany, in 2004, progress in growing new kid-
neys in situ (renal organogenesis) to treat end-stage renal
disease (ESRD) was reviewed [1]. Here, I will summarize
parallel work relating to organogenesis of endocrine pan-
creas as a treatment for type 1 diabetes mellitus, a major
cause of ESRD.
Transplantation of pancreatic islets is a proven but still
experimental means to treat type 1 diabetes mellitus. The
shortage of human islet donors is such that it will not be
possible to meet the demand [2]. Limited availability of
islets could be overcome through use of tissue derived
from pigs since humans are sensitive to porcine insulin,
and islets are not subject to humoral rejection posttrans-
plantation from pigs to humans [3, 4]. Unfortunately, the
limited experience with pig to human islet transplanta-
tion suggests that even large quantities of transplanted
porcine islets will not translate into insulin sufficiency for
human hosts [4]. It is likely that cellular trauma inherent
in isolation procedures results in diminished islet viability
postimplantation. Coupled with the limited replication
potential for insulin-secreting beta cells within mature
islets, diminished viability results in a declining pool of
functioning engrafted islets over time [2]. A strategy to
overcome the limited potential for growth/division of ma-
ture islet cells is to transplant fetal pancreatic tissues
(pancreatic anlagen) that have a capacity for beta cell
expansion postimplantation [5, 6]. One advantage of this
strategy is that exocrine pancreatic tissue does not dif-
ferentiate following isotransplantation or allotransplan-
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tation of pancreatic anlagen obviating complications that
might result from exocrine pancreatic components [5, 6].
We have transplanted pancreatic anlagen from rat or
pig embryos into the peritoneal membranes of rodents
[7, 8] using techniques developed for the transplantation
of renal anlagen [1]. By 2 weeks posttransplantation of
whole pancreatic anlagen from embryonic (E) day E12.5
Lewis rats into the omentum of a Lewis rat, the tissue
has undergone differentiation and insulin-positive islets
of Langerhans can be delineated amidst stroma. No dif-
ferentiation of exocrine pancreatic tissue occurs under
these conditions. Abnormal glucose tolerance in strep-
tozotocin diabetic hosts can be normalized within 2 to
4 weeks posttransplantation of pancreatic primordia as
can the pattern of abnormal weight gain over time that is
characteristic of diabetic animals [7, 8].
To establish the feasibility of pig-to-rodent xenotrans-
plantation of pancreatic anlagen, we implanted pancre-
atic anlagen from day E28 pig embryos into adult Lewis
rats. Shown in Figure 1A is a photomicrograph of a
day E28 pig pancreas with dorsal pancreas and ventral
pancreas components delineated. An accumulation of
fat surrounds pig pancreatic anlagen implanted 3 weeks
previously adjacent to an omental vessel (Fig. 1A, ar-
row). Remarkably, if pig pancreatic anlagen are obtained
within a developmental “window: prior to day E35 [9], the
anlagen engraft postimplantation into nonimmunosup-
pressed immunocompetent diabetic rat hosts. Glucose
tolerance in streptozotocin diabetes in rats is normalized
permanently by the physiologic secretion of porcine in-
sulin from transplanted pig pancreatic anlagen [8, 9].
Figure 2 shows tissues from rats into which pancre-
atic anlagen had been transplanted 20 weeks previously.
Relative to an age-matched sham-transplanted diabetic
control (Fig. 2A) the omentum in transplanted rats con-
tains an increased quantity of fat (Fig. 2B). Omentum
from a rat into which a pancreatic anlagen from a day
E12.5 Lewis rat embryo had been implanted 20 weeks
previously contains adipocytes with characteristic flat-
tened nuclei (Fig. 2C), as does omentum from a Lewis rat
into which pig pancreatic anlagen had been implanted
20 weeks previously (Fig. 2D, arrowheads). However,
omentum from the rat into which the embryonic pig
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Fig. 2. Photographs (A and B) and photomi-
crographs (C to G) of omentum from diabetic
rats. (A) Omentum from a rat that under-
went sham transplantation 20 weeks previ-
ously. (B) Omentum from a rat into which
five pig pancreatic anlagen had been trans-
planted 20 weeks previously (arrows delin-
eate fat). (C) Hematoxylin and eosin–stained
section of omentum from a Lewis rat into
which 10 Lewis rat pancreatic anlagen had
been transplanted 20 weeks previously. (D)
Hematoxylin and eosin–stained section of
omentum from a rat into which five pig
pancreatic anlagen had been transplanted
20 weeks previously. Arrowheads delineate
flattened nuclei, arrows, rounded nuclei. (E
to G) Sections of omentum from a Lewis
rat into which five pig pancreatic anlagen
had been transplanted 20 weeks previously.
(E) A control antibody-stained section. (F)
An anti-insulin antibody-stained section. (G)
A combined Gomori-stained section. Arrows
delineate cells. Magnification is shown in (B)
[for (A) and (B)], (D) [for (C and (D)], and
in (G) [for (E) to (G)]. Reproduced with per-
mission [8].
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Fig. 1. Photographs of embryonic (E) day E28 pig pancreas. (A) The
dorsal pancreas (dp), the ventral pancreas (vs), and duodenum (duo) are
shown in this untampered pancreas. (B) Day E28 pig pancreas 3 weeks
after implantation in the omentum of a host rat. The fat accumulation is
shown (arrow). Magnifications are shown. Reproduced with permission
[8].
pancreas had been transplanted is more cellular than that
into which the rat anlagen had been transplanted and
also contains cells in clusters with larger rounded nuclei
(Fig. 2D, arrows). These cells have the morphology of
engrafted transplanted beta cells (∼ round with large nu-
cleus and granular cytoplasm), do not stain with control
antibody (Fig. 2E, arrow), are insulin-positive (Fig. 2F,
arrow), and contain Gomori-positive granules (Fig. 2G,
arrow) characteristic of beta cells. Some of these cells are
also glucagon-positive [8].
Rather than islets surrounded by stroma [7] individual
endocrine (alpha and beta) cells engraft within the omen-
tum after pig to rat pancreatic primordia transplantation
(Fig. 2) [8, 9]. While we do not know for certain why this is
the case, it may reflect the inability of individual pig islet
cells to coalesce into islets in the setting of a xenogeneic
(rat) extracellular matrix [10]. The highly atypical way in
which pig pancreatic anlagen differentiate after implan-
tation in a rat is likely to explain the fortuitous tolerance
to the transplanted pig pancreatic tissue in host rats.
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